Antigen stability

Antigen stability refers to the structural and conformational integrity of a protein antigen, a critical biophysical parameter that determines its fate within the antigen-processing compartments of antigen-presenting cells (APCs) [1, 2]. It is not a single therapeutic target molecule, such as a receptor or enzyme, but rather a biological characteristic that influences the efficiency and nature of the immune response induced by vaccines and therapeutic proteins [2, 10]. The stability of an antigen dictates its resistance to endolysosomal proteolysis; while hyper-stable proteins may resist degradation to the point of entering cross-presentation pathways for MHC class I display, proteins with moderate stability are typically required for efficient processing and loading onto MHC class II molecules [1, 10, 12]. In the context of drug and vaccine development, optimizing antigen stability is essential for maintaining immunogenicity, ensuring a consistent safety profile, and preventing the formation of protein aggregates that can trigger adverse immune reactions or reduce therapeutic efficacy [5, 9, 11]. Modulating this property through protein engineering or the use of specific stabilizers and adjuvants is therefore a primary focus in modern vaccinology and immunotherapy [3, 14].

Other names

Antigen conformational stabilityProtein fold stabilityStructural integrity of antigensFold-stability

Not applicable as it is a biophysical property rather than a molecular target; however, it is modulated via protein engineering to control the rate of proteolysis and MHC loading.